2) Tumor tissues
肿瘤组织
1.
Aim To investigate the relationship between the expres- sion of TNFRp55 and TNFRp75 in tumor tissues and tumor cell lines in vitro and the supression of novel rhTNF on these tumor cell lines growth.
目的 探讨ＴＮＦＲｐ５５和ＴＮＦＲｐ７５在各种肿瘤组织中的表达与新型ｒｈＴＮＦ对肿瘤细胞生长的抑制作用的关系。
2.
Objective To study the distribution and ratio of the two forms of hydroxycamptothecin in mice tumor tissues.
目的研究羟基喜树碱两种构型在肿瘤组织中的分布和比例关系。
3) tumor tissue
肿瘤组织
1.
Research on three fluorospectrophotometry methods for determination of concentration of adriamycin in tumor tissue;
三种荧光分光光度法测定肿瘤组织中阿霉素含量的研究
2.
Objective:To review the advance on regulation of vascular endothelial growth factor(VEGF) in tumor tissue by natural drugs.
目的:对天然药物对肿瘤组织中血管内皮生长因子(VEGF)调节作用研究现状进行综述。
3.
OBJECTIVE: To determine the content of lomustine in mouse tumor tissue.
目的：以反相高效液相外标法测定小鼠肿瘤组织内洛莫司汀的含量。
4) tissue microarray
组织芯片
1.
Tissue microarray expression of phosphoinositide 3-kinase regulatory subunit p85α,AKT2 and Ki-67 in ovarian cancer;
卵巢癌组织芯片中磷脂酰肌醇3激酶调节亚基p85α,AKT2及Ki-67表达
2.
Expression and clinical significance of protein-serine-threonine kinase 2 protein in human colorectal carcinoma using tissue microarray;
利用组织芯片技术研究丝氨酸/苏氨酸蛋白激酶2在大肠癌中的表达及其临床意义
3.
Biological significance of expression of calcyclin in human pancreatic carcinoma: a tissue microarray-based study;
应用组织芯片技术研究人类胰腺癌中钙结合蛋白表达的生物学意义
5) tissue chip
组织芯片
1.
Detection of Skp2 and p27~(kip1) expression in human renal cell carcinoma using tissue chip technique;
应用组织芯片技术研究Skp2、p27~kip1在肾细胞癌中的表达及意义
2.
By using tissue chip technique to analysis the expression of Ubiquitin,Skp2 and p27 in lung cancer;
采用组织芯片技术检测肺癌中泛素、Skp2、p27的表达
3.
Study on the expression of Ubiquitin,CyclinE and P27 in breast cancer by using tissue chip technique;
采用组织芯片技术检测乳腺癌中泛素、cyclinE和p27的表达
6) Tissue array
组织芯片
1.
Preparation of tissue array and applications of in situ analysis technology;
组织芯片制备与原位分析技术
2.
Methods Paraffin-embedded materials in 219 cases of lymphoma and 13 reactive proliferation lymph nodes were made up a tissue array.
方法 石蜡标本制作组织芯片,应用免疫组化S P法检测219例淋巴瘤及13例反应性增生淋巴结石蜡标本中survivin和bcl 2表达;同时应用RT PCR技术检测18例淋巴瘤、2例淋巴结反应性增生survivin和bcl- 2mRNA表达,并进行半定量分析。
3.
Methods The expression of uPA and uPAR in hepatoma were tested by using the S-P immunohistochemistry and tissue array.
方法通过组织芯片及免疫组化法测定HCC癌组织中uPA及其受体(uPAR)的表达,并与肝硬化及正常肝组织比较。
补充资料：睾丸多组织成分的生殖细胞性肿瘤
睾丸多组织成分的生殖细胞性肿瘤
病名。睾 丸生殖细胞性肿瘤之一。亦称睾丸混合性癌。该肿瘤由一种以上组织学类型所构成。如畸胎 瘤合并胚胎性瘤、精原细胞瘤合并胚胎性癌、畸胎瘤合并精原细胞瘤、胚胎性癌、畸胎瘤和 绒毛膜上皮癌混合等。其恶性程度及预后主要取决于肿瘤所含各种组织学类型的多少。治疗 亦需依肿瘤所含组织学类型及各自比例择之。参见各条。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条